Tim Luetkens

11PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cellular immunologyMolecular targetsVenereology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 22, 2026
Preventing trogocytosis by cathepsin B inhibition augments CAR T-cell function.

|Aug 06, 2025
A novel sweeping antibody exhibits efficient clearance of the cancer- and autoimmunity-associated cytokine interleukin 16.

Jillian M Baker, Alexander Wang, Kenneth A Dietze

|Jul 03, 2025
Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma.

Djordje Atanackovic, Tim Luetkens, Dina Schneider

|Jun 25, 2024
Preventing trogocytosis by cathepsin B inhibition augments CAR T cell function.

Kenneth A Dietze, Kiet Nguyen, Aashli Pathni

|Feb 19, 2024
Restricting CAR T Cell Trafficking Expands Targetable Antigen Space.

Erin A Morales, Kenneth A Dietze, Jillian M Baker

|Jul 19, 2023
Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity.

Erica R Vander Mause, Jillian M Baker, Kenneth A Dietze

Pageof 2

Frequent Collaborators

7 joint publications

Djordje Atanackovic

4 joint publications

Kenneth A Dietze

4 joint publications

Sabarinath Venniyil Radhakrishnan

3 joint publications

Jillian M Baker